Vylor Begins Life as Independent Seed and Genetics Company After Corteva Split

Corteva's seed and advanced genetics business is separating into Vylor on October 1, creating a new independent publicly traded agriculture company focused on seeds, licensing, gene editing and next-generation crop technologies.

Corteva shareholders of record as of September 24 are entitled to receive one Vylor share for each Corteva share held, with the distribution scheduled before the U.S. market opens on October 1.

Vylor common stock has been authorised for listing on the New York Stock Exchange under the ticker VYLR, while the remaining Corteva business continues as a crop protection company.

The separation creates two agriculture companies with very different capital and innovation profiles. Vylor will hold the former Corteva seed business, including major corn and soybean franchises and growth platforms in licensing, gene editing, hybrid wheat and biofuels.

The company says it holds more than 4,000 germplasm patents and more than 2,000 biotechnology patents, giving the new standalone business a large proprietary genetics portfolio from its first day.

Vylor has already outlined a pipeline that includes new corn yield and insect-control traits, four new soybean technology platforms through 2035 and proprietary hybrid wheat scheduled for commercial launch in late 2027.

The company is also creating an investment arm, Vylor Edge, to take equity stakes and form strategic partnerships with startups, universities and other agricultural technology developers.

For the seed industry, the split is more than a corporate restructuring. It creates a standalone global genetics company whose future valuation and investment priorities will be judged separately from the crop protection business that remains inside Corteva.